Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05946837 · ClinicalTrials.gov registry record · Phase 1
Near-infrared Fluorescence Lymphatic Imaging Assessment of Lymphatic Response to Pneumatic Back/Neck Lymphatic Drainage Delivered by a Pneumatic Manual Lymphatic Drainage Device
A Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT05946837 is a Phase 1 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 4 participants.
The verdict
NCT05946837, a Phase 1 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to objectively assess lymphatic function before, during, and immediately after Neuroglide treatment in lower trunk and leg lymphatic vessels, torso, axillary regions, inguinal regions, upper extremities, and cervical/neck and to determine any VAS (Visual Analog Scale, a commonly used measure of pain perception) score change after Neuroglide treatment.
Interventions
- DRUG Indocyanine green (ICG) dye
- DEVICE NIRF-LI imaging
- DEVICE Neuroglide pad
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2023-08-29 |
| Est. Completion | 2023-09-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05946837
The ClinicalTrials.gov registry entry for NCT05946837 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Indocyanine green (ICG) dye is the first listed.
NCT05946837 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05946837 about?
NCT05946837 is a clinical study titled "Near-infrared Fluorescence Lymphatic Imaging Assessment of Lymphatic Response to Pneumatic Back/Neck Lymphatic Drainage Delivered by a Pneumatic Manual Lymphatic Drainage Device". The purpose of this study is to objectively assess lymphatic function before, during, and immediately after Neuroglide treatment in lower trunk and leg lymphatic vessels, torso, axillary regions, inguinal regions, upper extremities, and cervical/neck and to determine any VAS (Visual Analog Scale, a ...
What is the current status of trial NCT05946837?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2023-08-29. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT05946837?
The interventions under investigation include: Indocyanine green (ICG) dye (DRUG), NIRF-LI imaging (DEVICE), Neuroglide pad (DEVICE).
Who is sponsoring clinical trial NCT05946837?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.